CombiMatrix Corporation (CBMX) Names Jeff Hayes Director of Sales for Oncology  
9/6/2011 10:38:31 AM

IRVINE, Calif., Sept. 6, 2011 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company performing DNA-based testing services for cancer and developmental disorders, today announced that diagnostics industry veteran Jeff Hayes has been named Director of Sales for the Oncology market. Hayes brings more than 20 years of experience in the biopharmaceutical and cancer diagnostics industries to the position, having held marketing management positions with Schering-Plough and Eli Lilly, as well as sales management roles with US LABS (now a division of LabCorp) and PLUS Diagnostics.